Connect with us


Brazil: Cannabis import orders grew 2400% since 2015



Listen to this article

Import requests for cannabis derivatives in Brazil increased by more than 2400%, from 850 in 2015 to more than 35 in 2021, according to data from Anvisa – National Health Surveillance Agency. In 2022, until the beginning of October, 58.245 requests for imports of cannabis-derived products for therapeutic purposes were processed in Brazil, which confirms that medical cannabis in Brazil is booming.

Requests for imports of cannabis derivatives for therapeutic purposes continue to increase in Brazil, revealing an average annual growth of around 400%, figures that could expand even further until the end of this year. If in 2015 there were 850 import requests, that number skyrocketed to 35.416 in just 6 years. The recent election of Lula da Silva as the new president of Brazil now brings new hope to the sector, because it could represent advances in the regulation of cannabis in Brazil, something totally unthinkable for the previous government of Jair Bolsonaro.

Lula did not express himself clearly in favor of legalization, but he also did not say he was against it, referring this decision to other instances than the government: “This is not an issue that the government has to deal with. This is an issue that either the National Congress handles, or the Supreme Court takes care of it,” he told reporters. flow podcast.

Source: Anvisa

Brazilian civil society has, for its part, been extremely active, having even overturned a CFM resolution – Federal Council of Medicine, which intended to limit the use and prescription of medical cannabis in the country only to cannabidiol.

In contradiction with Anvisa itself, which had published in October 2021 a product list cannabis derivatives approved for import, CFM received fierce criticism de various quadrants Brazilians and ended up revoking the Resolution days after its publication.

A Anvisa approved in 2021 the import of 249 cannabis derivatives into Brazil, of which five with THC and 244 based on CBD (cannabidiol). The authorized products followed a new resolution, with simpler rules for individual importation by Brazilian patients, but Anvisa clarified at the time that “it did not evaluate the effectiveness, quality or safety of the products”, referring to the legislation of the countries of origin.

Click here to comment
Notify of
Inline feedback
View all comments

Watch the Documentary "Patients"

Documentary Patients Laura Ramos help us grow

Mais recentes

International4 days ago

Luxembourg: new government freezes cannabis legalization

Luxembourg's ambitious plan for the full legalization of recreational cannabis markets has been put on hold by the new government...

International6 days ago

Europol and EMCDDA report warns of trafficking problems. Cannabis market in Europe is worth more than 11.4 billion a year

A joint analysis by EMCDDA and Europol, entitled “EU Drug Market: Cannabis”, released last week, warns that the market...

International1 weeks ago

Syqe Air approved in Australia as a medical device. Israeli company could be bought by Phillip Morris for more than 600 million dollars

Syqe Medical announced that its vaporizer, Syqe Air, has been approved by Australian health authorities as a medical device....

International2 weeks ago

Australia: Medical Association warns of risks of recreational cannabis use

In a context of intense debates about the legalization of recreational cannabis in Australia, the Australian Medical Association (AMA) submitted a...

International2 weeks ago

Italy: Researchers find evidence of cannabis use in the XNUMXth century in Milan

Archaeotoxicological discoveries have revealed the recreational use of cannabis in XNUMXth century Europe. Analysis of bones from hospital patients...

Events2 weeks ago

Cannadouro returns to Alfândega do Porto next weekend

It is definitely the meeting place for cannabis culture in Portugal. On the 18th and 19th of November this year,...

corporations2 weeks ago

Organigram receives strategic investment of 124,6 million from British American Tobacco

Organigram Holdings Inc., a Canadian cannabis producer, announced a strategic investment of 124,6 million Canadian dollars from...

International2 weeks ago

Germany: Legalization may only happen in 2024, with postponement of the vote in the Bundestag

Advances in legislation to regulate cannabis in Germany have suffered yet another delay. According to MarijuanaMoment, the vote...

International3 weeks ago

Sidarta Ribeiro winks at Baudelaire with “As Flores do Bem”

The renowned Brazilian scientist, Sidarta Ribeiro, recently released a book that promises to challenge prejudices about cannabis and contribute to...

National3 weeks ago

Portugal: Prime Minister, António Costa, resigns over suspicions of corruption

The Prime Minister of Portugal, António Costa, presented his resignation to the President of the Republic, Marcelo Rebelo de Sousa, this afternoon, in...